Sofgen Pharma S.A 20-F for FY2022
Sofgen Pharma S.A. (PROCF)
20-F
2023-05-12
For: 2022-12-31
View Original
Added on
April 06, 2026
About this 20-F
Sofgen Pharma S.A filed this 20-F on May 12, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $409.92M
- unchanged from $409.74M a year earlier
- Net income
- $42.54M
- compared with a net loss of $100.86M a year earlier
- Diluted EPS
- $0.50
- compared with -$1.03 a year earlier